,,iv  #aaf? ,,congress  #b;d ,session   
,h4 ,,res4 #ajjd  ,,9 ,,! ,,h\se ,,(    
,,repres5tatives  ,june #ae1 #bjbj,mr4  
,ma/ 7= himself1 ,ms4 ,s*ak[sky1 ,mr4   
,gallagh]1 & ,mr4 ,langev97 submitt$ !  
foll[+ resolution2 :i* 0 ref]r$ to !    
,committee on ,en]gy & ,comm]ce         
,,resolution  ,express+ support = !     
designation ( ,july #bb1 #bjbj1 z       
,gliobla/oma ,aw>5ess ,day4  ,:]eas m   
?an #ac1jjj new cases ( gliobla/oma w be
 diagnos$ 9 ! ,unit$ ,/ates 9 #bjbj2    
,:]eas gliobla/oma is-- 7#a7 ! mo/      
common malignant 7canc]\s7 bra9 tumor1  
acc\nt+ = #dh p]c5t ( all prim>y        
malignant bra9 tumors2 &  7#b7 ! mo/    
aggressive1 complex1 difficult to treat1
 & deadly type ( bra9 tumor2 ,:]eas x is
 e/imat$ t m ?an #aj1jjj individuals 9 !
 ,unit$ ,/ates w succumb to gliobla/oma 
e ye>2 ,:]eas ! #e-ye> survival rate =  
gliobla/oma pati5ts is only #f4h p]c5t1 
& ! av]age l5g? ( survival = gliobla/oma
 pati5ts is e/imat$ to be only #ab to   
#ah mon?s2 ,:]eas gliobla/oma is        

describ$ z a disease t affects ! ess5ce 
( self1 z ! treatm5t & removal (        
gliobla/oma pres5ts significant *all5ges
 due to ! uniquely complex & fragile    
nature ( ! bra91 ! prim>y organ 9 !     
human body t controls n only cognitive  
ability1 b also ! actions ( e organ &   
limb2 ,:]eas1 relative to o!r types (   
canc]s1 bra9 canc] has-- 7#a7 ! highe/  
p]-pati5t initial co/ ( c>e1 ) an       
annualiz$ mean net co/ ( c>e approa*+   
#aej1jjj2 &  7#b7 ! highe/ annualiz$    
mean net co/s = la/-ye>-(-life c>e1 ) a 
co/ ( betwe5 #ace1jjj & #baj1jjj p]     
pati5t1 dep5d+ on ! age & g5d] ( a      
pati5t2 ,:]eas1 al?\gh rese>* advances  
may fuel ! developm5t ( new treatm5ts = 
gliobla/oma1 *all5g+ ob/acles to        
accel]at+ progress t[>d new treatm5ts = 
gliobla/oma rema91 & !re are no scre5+  
or e>ly detection me?ods2 ,:]eas1 al?\gh
 gliobla/oma 0 fir/ describ$ 9 m$ical & 
sci5tific lit]ature 9 ! #aibjs1 &       
despite its deva/at+ prognosis1 only #d 
drugs & #a m$ical device h be5 approv$  

by ! ,food & ,drug ,adm9i/ration to     
treat gliobla/oma s9ce ! #aibjs1 & !    
mortality rates associat$ ) gliobla/oma 
h *ang$ little dur+ ! pa/ #cj ye>s2 &   
,:]eas !re is a ne$ = great] public     
aw>5ess ( gliobla/oma1 includ+ aw>5ess (
 bo?-- 7#a7 ! urg5t unmet m$ical ne$s ( 
gliobla/oma pati5ts2 &  7#b7 !          
opportunities = rese>* & treatm5t       
advances = gliobla/oma3 ,n[1 !re=e1 be x
  ,t ! ,h\se ( ,repres5tatives-- 7#a7   
supports ! designation ( ,gliobla/oma   
,aw>5ess ,day2  7#b7 enc\rages increas$ 
public aw>5ess ( gliobla/oma2  7#c7     
honors ! individuals :o h lo/ _! lives  
to gliobla/oma1 a deva/at+ disease1 or  
are curr5tly liv+ ) x2  7#d7 supports   
ef=ts to develop bett] treatm5ts =      
gliobla/oma t w improve ! long-t]m      
prognosis ( individuals diagnos$ )      
gliobla/oma2  7#e7 expresses its support
 = ! individuals :o are battl+ bra9     
tumors1 z well z ! families1 fri5ds1 &  
c>egiv]s ( ^? individuals2 &  7#f7 urges
 a collaborative approa* to bra9 tumor  

rese>*1 :i* is a promis+ means ( advanc+
 ! und]/&+ & treatm5t ( gliobla/oma4